Publication | Closed Access

The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide

Metabolic SyndromeBiochemistryAtp-sensitive K+ ChannelsMedicineDiabetesPhysiologyInsulin ManagementNew Anti-diabetic DrugEndocrinologyInsulin SecretionMetabolismPharmacologyInsulin SignalingHealth Sciences